InvestorsHub Logo
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: georgejjl post# 215329

Saturday, 10/19/2019 10:20:22 AM

Saturday, October 19, 2019 10:20:22 AM

Post# of 458377
Very interesting and important (for Anavex) publication released yesterday 10/18/19. Thank you georgegii.

“Metabolic Mitochondria Dysfunction May Be Primary Cause of Alzheimer’s
A team of researchers led by Yale-NUS College says it has found evidence that metabolic dysfunction is a primary cause of Alzheimer’s disease.”
https://www.genengnews.com/news/metabolic-mitochondria-dysfunction-may-be-primary-cause-of-alzheimers/


And just 5 days ago Alzheimer’s News Today has this to say about our compound:

“Anavex 2-73 is a small molecule that activates the sigma-1 receptor, which is known to modulate cellular processes relevant to neurodegeneration. Specifically, Anavex 2-73 is thought to help restore cellular balance by targeting protein misfolding (when proteins fail to fold correctly, into a normal configuration, they do not work as intended), oxidative stress (which damages cells due oxygen molecules with free radicals, or unpaired electrons), mitochondrial dysfunction, inflammation, and cellular stress.”

https://alzheimersnewstoday.com/anavex-2-73/

The picture is coming more and more into focus. At least for those willing to think clearly.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News